Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000996773 | SCV000570283 | likely benign | not provided | 2021-05-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000527151 | SCV000656796 | uncertain significance | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2017-09-11 | criteria provided, single submitter | clinical testing | In summary, this variant has uncertain impact on CACNA1A function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the deleted amino acids is currently unknown. This variant has not been reported in the literature in individuals with a CACNA1A-related disease. ClinVar contains an entry for this variant (Variation ID: 421166). While this variant is present in population databases (rs770368215), the frequency information is unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant, c.6650_6661delACCACCACCATC, results in the deletion of 4 amino acid(s) of the CACNA1A protein (p.His2217_His2220del), but otherwise preserves the integrity of the reading frame. |
Ce |
RCV000996773 | SCV001151689 | likely benign | not provided | 2017-01-01 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001814984 | SCV002062029 | likely benign | not specified | 2019-12-11 | criteria provided, single submitter | clinical testing |